| Product Code: ETC4746743 | Publication Date: Nov 2023 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The import shipments of influenza vaccines to Suriname in 2024 saw a significant increase in concentration, with high concentration levels in 2023 escalating to very high concentration in 2024, indicating a more consolidated market. The top exporting countries to Suriname for influenza vaccines in 2024 were Brazil, India, United States of America, Netherlands, and France. The compounded annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 10.35%, demonstrating steady expansion. Furthermore, the impressive growth rate from 2023 to 2024 at 111.98% suggests a substantial surge in demand for influenza vaccines in Suriname.

Suriname's Influenza Vaccine market is anticipated to experience a stable growth rate of 2.44% by 2027, reflecting trends observed in the largest economy Brazil, followed by Mexico, Argentina, Colombia and Chile.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Influenza Vaccine Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Influenza Vaccine Market Revenues & Volume, 2022 & 2032F |
3.3 Suriname Influenza Vaccine Market - Industry Life Cycle |
3.4 Suriname Influenza Vaccine Market - Porter's Five Forces |
3.5 Suriname Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2022 & 2032F |
3.6 Suriname Influenza Vaccine Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.7 Suriname Influenza Vaccine Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.8 Suriname Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2022 & 2032F |
3.9 Suriname Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
4 Suriname Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname Influenza Vaccine Market Trends |
6 Suriname Influenza Vaccine Market Segmentations |
6.1 Suriname Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2022 - 2032F |
6.1.3 Suriname Influenza Vaccine Market Revenues & Volume, By Trivalent, 2022 - 2032F |
6.2 Suriname Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Influenza Vaccine Market Revenues & Volume, By Seasonal, 2022 - 2032F |
6.2.3 Suriname Influenza Vaccine Market Revenues & Volume, By Pandemic, 2022 - 2032F |
6.3 Suriname Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Suriname Influenza Vaccine Market Revenues & Volume, By Egg-based, 2022 - 2032F |
6.3.3 Suriname Influenza Vaccine Market Revenues & Volume, By Cell-based, 2022 - 2032F |
6.4 Suriname Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Suriname Influenza Vaccine Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.4.3 Suriname Influenza Vaccine Market Revenues & Volume, By Adult, 2022 - 2032F |
6.5 Suriname Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Suriname Influenza Vaccine Market Revenues & Volume, By Injection, 2022 - 2032F |
6.5.3 Suriname Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2022 - 2032F |
7 Suriname Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Suriname Influenza Vaccine Market Export to Major Countries |
7.2 Suriname Influenza Vaccine Market Imports from Major Countries |
8 Suriname Influenza Vaccine Market Key Performance Indicators |
9 Suriname Influenza Vaccine Market - Opportunity Assessment |
9.1 Suriname Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2022 & 2032F |
9.2 Suriname Influenza Vaccine Market Opportunity Assessment, By Type, 2022 & 2032F |
9.3 Suriname Influenza Vaccine Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.4 Suriname Influenza Vaccine Market Opportunity Assessment, By Age Group, 2022 & 2032F |
9.5 Suriname Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
10 Suriname Influenza Vaccine Market - Competitive Landscape |
10.1 Suriname Influenza Vaccine Market Revenue Share, By Companies, 2025 |
10.2 Suriname Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here